The Department of Defense, General Services Administration, and National Aeronautics and Space Administration today released a proposed rule intended to support domestic production of products critical to national and economic security. The rule would apply enhanced price preferences to certain critical supply chain products purchased by the federal government and require higher domestic content in products the government purchases under the Buy American Act, as directed by President Biden in a January executive order.  

“As the pandemic made clear, supply chain disruptions can impact the health, safety, and livelihoods of Americans — leaving us without access to critical goods during a crisis,” the White House said in a fact sheet on the rule. “Some products are simply too important to our national and economic security to be dependent on foreign sources.”

The agencies will accept comments on the rule for 60 days after its publication in the July 30 Federal Register. 
 

Related News Articles

Headline
Baxter has resumed production on all of its 3-liter irrigation and peritoneal dialysis solutions manufacturing lines, the company announced Dec. 5. The company…
Headline
The Food and Drug Administration Dec. 4 announced empty IV bags have been added to its Medical Device Shortages List, and that the shortage is estimated to…
Headline
Baxter Nov. 26 announced new allocation levels for multiple IV product groups and advised customers of a one- to two-week lead time for products to flow…
Headline
Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced Nov. 7. Along with the first line that resumed…
Headline
Supplies of Mo-99/Tc-99M, which are medical radioisotopes used in procedures to diagnose and detect diseases including heart disease and cancer, are…
Headline
Baxter announced Oct. 31 that it has restarted its North Cove, N.C. facility's highest-throughput IV solutions manufacturing line, which normally accounts for…